the Soy Story
HOME MEDIA RELEASES WHAT'S NEW IN RESEARCH? INTERVIEW CONTACTS GLOSSARY
Search
What is Soy?
Soy Foods for Health
Soy and Heart Disease
Soy and Cancer
Soy and Osteoporosis
Soy and Women's Health
Soy and Diabetes
Soy and Infant Formula
Soy and Sports Nutrition
Commonly Asked Questions
Bibliography/Reference
Soy & Diabetes

References for Soy & Diabetes:

  1. Tuomilehto J, Lindstrom J, Eriksson JG et al., Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance, N Engl J Med 2001;344:1343-1350.
  2. Brand Miller J & Foster-Powell K, The Glucose Revolution: GI Plus, Hodder, Sydney 2000.
  3. Yang G, Shu XO, Jin F et al., Soyfood consumption and risk of glycosuria: a cross-sectional study within the Shanghai Women's Health Study, Eur J Clin Nutr 2004;58:615-620.
  4. Feskens EJ, Virtanen SM, Rasanen L et al., Dietary factors determining diabetes and impaired glucose tolerance. A 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study, Diabetes Care 1995;18:1104-1112.
  5. Cheng SY, Shaw NS, Tsai KS et al., The hypoglycemic effects of soy isoflavones on postmenopausal women, J Womens Health (Larchmt) 2004;13:1080-1086.
  6. Jayagopal V, Albertazzi P, Kilpatrick ES et al., Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes, Diabetes Care 2002;25:1709-1714.
  7. Kannel WB & McGee DL, Diabetes and cardiovascular disease. The Framingham study JAMA 1979;241:2035-2038.
  8. Hermansen K, Sondergaard M, Hoie L et al., Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects, Diabetes Care 2001;24:228-233.
  9. Teixeira SR, Tappenden KA, Carson L et al., Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy, J Nutr 2004;134:1874-1780.
  10. Azadbakht L, Shakerhosseini R, Atabak S et al., Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy, Eur J Clin Nutr 2003;57:1292-1294.
  11. Teixeira SR, Tappenden KA, Erdman JW Jr, Altering dietary protein type and quantity reduces urinary albumin excretion without affecting plasma glucose concentrations in BKS.cg-m +Lepr db/+Lepr db(db/db) mice, J Nutr 2003;133:673-678.
  12. Matsuzawa Y, Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease, Atheroscler Suppl. 2005;6:7-14.
  13. Colditz GA, Willett WC, Rotnitzky A et al., Weight gain as a risk factor for clinical diabetes mellitus in women, Ann Intern Med 1995;122:481-486.
  14. Dunstan D, Zimmet P, Welborn T et al., on behalf of the AusDiab Steering Committee, Diabesity & associated disorders in Australia 2000, Melbourne, International Diabetes Institute, 2001.
  15. Ministry of Health, A Portrait of Health: Key results of the 2002/03 New Zealand Health Survey, Wellington 2004, Ministry of Health.
  16. Diabetes New Zealand website [www.diabetes.org.nz] accessed 21st June 2005.
  17. Diabetes Atlas, International Diabetes Federation website [www.idf.org] accessed 21st June 2005.